Prot #VY-HTT01-1: A Phase 1b, Open-Label, Randomized, Controlled, Multicenter, Dose Escalation Study of the Safety, Tolerability, and Biological Effects of VY-HTT01 Administered Via Intraparenchymal Infusion of the Putamen and Thalamus in Adults with Hunt

Project: Research project

Project Details

StatusActive
Effective start/end date11/8/2111/8/22

Funding

  • Voyager Therapeutics, Inc. (Prot #VY-HTT01-1)